Is HLNE a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Hamilton Lane (HLNE) rests on Evergreen and private-wealth distribution: The evergreen platform passed $19 billion in AUM with roughly $640 million of net inflows in the June 2026 quarter, and it carries higher fee rates than the institutional separate-account book. The bear case rests on the accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Analysts covering it publish targets from $103.00 to $170.00 against a $90.50 share price on November 16, 2026, so even the professionals disagree by 53% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

HLNE key stats

At $90.50 on November 16, 2026, Hamilton Lane (HLNE) has a market cap of $6.1B, a P/E of 13.4 on trailing earnings (12.0 on forward earnings) and a dividend yield of 2.65%. It next reports earnings around February 2, 2027 (estimated).

Market cap
$6.1B
P/E (trailing)
13.4
P/E (forward)
12.0
EPS (trailing 12 months)
$6.74
Price to book
3.9
Dividend yield
2.65%
Beta
1.17
Next earnings
around February 2, 2027 (estimated)

Market cap, P/E and yield are measured at the $90.50 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Hamilton Lane (HLNE)?

The last two weeks for Hamilton Lane, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • HLNE closed at $90.50 on November 16, 2026, down 5.6% over the past five trading days (from $95.87).
  • Hamilton Lane next reports quarterly results around February 2, 2027 (estimated).
  • On November 3, 2026, Hamilton Lane filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 3, 2026, Hamilton Lane filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 6, 2026, UBS raised its target to $120.00 from $115.00 (Buy).
  • On November 4, 2026, JP Morgan lowered its target to $144.00 from $150.00 (Overweight).
  • On November 4, 2026, Wells Fargo raised its target to $114.00 from $103.00 (Overweight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Hamilton Lane Incorporated is a private-markets investment and advisory firm founded in 1991 and listed on Nasdaq since 2017, with roughly 800 professionals across North America, Europe, Asia Pacific and the Middle East. It sits between institutional investors and private-markets fund managers rather than running buyouts itself. The business has three revenue shapes. Customized separate accounts are discretionary mandates run for pensions, insurers and sovereign funds. Specialized funds are commingled vehicles covering secondaries, co-investment and direct equity, private credit, infrastructure and impact, and this is where fee rates are highest. Advisory and technology work (reporting, monitoring, portfolio construction and the Cobalt analytics platform) covers a far larger asset base at much thinner economics. As of June 30, 2026 the firm reported roughly $1.1 trillion in assets under management and supervision, split between about $146.3 billion of discretionary assets and about $914.1 billion of non-discretionary advisory assets. The number that actually drives revenue is fee-earning AUM, which was about $83.7 billion at the end of the June 2026 quarter, up roughly 12% year over year, with specialized-fund fee-earning AUM at about $42.6 billion (up about 25%) at a blended rate near 69 basis points. Quarterly revenue was about $275 million and fee-related earnings about $124 million, up roughly 49% year over year at a margin near 53%. The evergreen platform, the semi-liquid vehicles sold through wirehouses, RIAs and private banks, passed $19 billion in AUM with about $640 million of net inflows in the quarter, and is the growth engine management points at most often. The complication is that in April 2026 a short-seller report from Hunterbrook questioned how fee-related earnings are presented, specifically the inclusion of incentive revenue tied to unrealized marks and the exclusion of stock-based compensation, and several plaintiff firms opened investigations afterward. The June quarter itself beat expectations, with EPS of $1.94 against a $1.59 consensus, yet the stock kept sliding: it closed at about $81.59 on October 16, 2026, down roughly 40% year to date and 31% over a year, from a 52-week high near $156. On October 15, 2026 the firm reshuffled its leadership: chairman Hartley Rogers became co-CEO alongside Juan Delgado-Moreira, and co-CEO Erik Hirsch moved to executive co-chairman to lead strategic growth initiatives. Days earlier it announced a partnership with Chubb Wealth to offer its private-markets funds in Hong Kong. The roughly $5.5 billion market capitalization against about $858 million of trailing revenue is best read as the market pricing both the growth and the earnings-quality dispute at the same time. The next report, for the September quarter, is due November 3, 2026.

The bull case: what would have to be true for $170.00

The most optimistic published target on HLNE is $170.00, +87.8% from the $90.50 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Evergreen and private-wealth distribution.

The evergreen platform passed $19 billion in AUM with roughly $640 million of net inflows in the June 2026 quarter, and it carries higher fee rates than the institutional separate-account book. These vehicles raise capital continuously instead of in closed-end vintages, which smooths the fundraising cycle that has historically made results lumpy. How much shelf space Hamilton Lane keeps against far larger sponsors pushing their own semi-liquid products is the open question. The October 2026 Chubb Wealth partnership in Hong Kong adds an Asian private-wealth distribution channel.

2. Specialized-fund fee-earning AUM.

Specialized-fund fee-earning AUM reached about $42.6 billion, up roughly 25% year over year, at a blended rate near 69 basis points. Secondaries and co-investment are the flagships here, and both benefit when the private-markets exit window stays slow and limited partners look for liquidity. With multiple funds in market, the step-ups from new vintages are the most visible near-term driver of management-fee growth.

3. Incentive fees and the quality-of-earnings debate.

Carried interest and incentive fees add real upside but arrive unevenly, and part of the evergreen incentive accrual is tied to NAV appreciation rather than realized exits. That is the exact practice Hunterbrook challenged in April 2026, alongside the exclusion of stock-based compensation from fee-related earnings. Whether reported FRE growth is accepted as a recurring measure will influence the multiple as much as the underlying flows will.

4. Capital return and the Up-C structure.

The declared quarterly dividend of $0.60 puts the fiscal 2027 target at $2.40 per share, an 11% increase over the prior year, which works out to roughly a 2.9% yield at the October 16, 2026 price near $81.59 and about a third of trailing earnings. The business is asset-light and converts fees to cash well, which is what funds the raise. Class A holders own only part of the economics of the underlying partnership, with Class B super-voting shares and a tax receivable agreement sitting above them.

5. Leadership transition.

On October 15, 2026 Hamilton Lane named chairman Hartley Rogers, a board member since 2004, co-CEO alongside Juan Delgado-Moreira, while Erik Hirsch, co-CEO until then and with the firm for more than 25 years, became executive co-chairman leading long-term strategic initiatives. The company framed it as a continued evolution of Hirsch's role amid technological change and an expanding client base. Because it arrives while the stock is down about 40% for the year and the short-report questions remain open, investors will be watching whether the new structure changes strategy, disclosure or capital allocation.

The bear case: what would have to be true for $103.00

The most pessimistic published target is $103.00, +13.8% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Hamilton Lane is worth if the risks below bite instead of the drivers above.

The accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Second, incentive fees and carried interest depend on exits, so a prolonged slow market for private-markets realizations can flatten the most profitable revenue line for several quarters. Third, fundraising is episodic, and a specialized fund that raises below its predecessor shows up directly in fee-earning AUM. Fourth, the evergreen push depends on distribution partners who can reallocate shelf space to Blackstone, Apollo, Ares or Blue Owl at any time, and semi-liquid funds carry redemption risk if private marks fall. Finally, the roughly $914 billion advisory book is large but low-fee, and clients that build internal teams or renegotiate retainers can shrink it without any change in market conditions. A leadership change at the top, announced October 15, 2026, adds transition risk while those questions are unresolved.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding HLNE already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on HLNE

8 analysts cover HLNE, with an average target of $126.00 (+39.2% against $90.50) and a split of 7 buy, 1 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the HLNE forecast and price target page.

How is HLNE valued?

Market cap, P/E and dividend yield at today's price are in the HLNE key stats above. The business figures below come from Hamilton Lane's reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$858 million (June 2026 quarter ~$275 million, up ~57% YoY)
  • Margins (TTM): ~46% operating, ~32% net
  • Fee-earning AUM: ~$83.7 billion, up ~12% year over year (June 30, 2026)
  • Assets under management and supervision: ~$1.1 trillion (~$146.3 billion discretionary, ~$914.1 billion advisory)
  • Dividend: $0.60 quarterly, $2.40 targeted for fiscal 2027 (~2.9% yield), up ~11%

As of October 2026: Hamilton Lane runs on an April-to-March fiscal year, so the quarter ended June 30, 2026 is its fiscal 2027 first quarter. Fee-related earnings of about $124 million on roughly $275 million of quarterly revenue is the number bulls anchor on and the number the short case attacks, because it includes incentive revenue linked to unrealized marks and excludes stock-based compensation. After a 40% decline the stock trades at about 12 times trailing and 11 times forward earnings and about 6.4 times trailing revenue, against a mean analyst target near $127; analysts expect the September quarter, reported November 3, 2026, to show EPS near $1.69 on about $210 million of revenue. Comparing the multiple to Blackstone or Ares also requires adjusting for the Up-C structure, where the listed Class A shares represent only a portion of the economics of the underlying operating partnership.

How do you decide if HLNE is a buy?

Whether HLNE is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold HLNE indirectly through an index or sector ETF before adding more.

What would change your mind on HLNE

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Evergreen and private-wealth distribution stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the HLNE stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HLNE against your real portfolio and see your actual exposure before deciding.

Your questions about Hamilton Lane

Ask Walnut's AI anything about HLNE and see how it fits what you own.

FAQ

Is HLNE a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Evergreen and private-wealth distribution, with revenue (ttm) at ~$858 million (June 2026 quarter ~$275 million, up ~57% YoY). The bear case rests on the accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Analysts covering it are spread from $103.00 to $170.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell HLNE?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $103.00, +13.8% from the $90.50 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for HLNE?

+

Evergreen and private-wealth distribution. The evergreen platform passed $19 billion in AUM with roughly $640 million of net inflows in the June 2026 quarter, and it carries higher fee rates than the institutional separate-account book. The most optimistic analyst target on HLNE is $170.00, +87.8% from the $90.50 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for HLNE?

+

The accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Second, incentive fees and carried interest depend on exits, so a prolonged slow market for private-markets realizations can flatten the most profitable revenue line for several quarters. Third, fundraising is episodic, and a specialized fund that raises below its predecessor shows up directly in fee-earning AUM. Fourth, the evergreen push depends on distribution partners who can reallocate shelf space to Blackstone, Apollo, Ares or Blue Owl at any time, and semi-liquid funds carry redemption risk if private marks fall. Finally, the roughly $914 billion advisory book is large but low-fee, and clients that build internal teams or renegotiate retainers can shrink it without any change in market conditions. A leadership change at the top, announced October 15, 2026, adds transition risk while those questions are unresolved. The most pessimistic published target is $103.00, +13.8% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Hamilton Lane do?

+

Private-markets allocator earning management and advisory fees on separate accounts, secondaries and co-investment funds, plus evergreen wealth products.

What would have to change for HLNE to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Evergreen and private-wealth distribution) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the accounting dispute is the first-order risk, and the share price shows it (down about 40% year to date to roughly $82 by October 16, 2026, even after a quarterly EPS beat): the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Hamilton Lane actually do?

+

It allocates capital into private markets on behalf of institutions and, increasingly, individual investors. It picks and monitors private equity, private credit, secondaries, infrastructure and co-investment exposure through customized separate accounts, commingled specialized funds, and advisory mandates. It is not a buyout firm and generally does not control operating companies itself.

How does Hamilton Lane make money?

+

Mostly through management and advisory fees charged on fee-earning AUM, which was about $83.7 billion as of June 30, 2026 at a blended rate near 69 basis points on specialized funds. On top of that sit incentive fees and carried interest, which are far more variable because they depend on fund performance and, in the evergreen vehicles, on NAV appreciation. Technology and reporting services add a smaller recurring stream.

Why is fee-earning AUM so much smaller than the $1.1 trillion headline?

+

The $1.1 trillion figure is assets under management and supervision, and roughly $914 billion of it is non-discretionary advisory assets that Hamilton Lane reports on or advises against for flat or retainer-style fees. Only about $83.7 billion is fee-earning AUM in the sense that a percentage-of-assets management fee applies. Anyone valuing the stock on the trillion-dollar number will badly overstate the revenue base.

Walnut is informational, not investment advice, and gives no verdict on HLNE. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks